PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Experimental Research, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou 510060, P. R. China.\', \'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510182, P. R. China.\', \'Guangdong Provincial Institution of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, P. R. China.\', \'State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, P. R. China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1021/acsnano.0c08379
?:doi
?:hasPublicationType
?:journal
  • ACS nano
is ?:pmid of
?:pmid
?:pmid
  • 33464829
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.203
?:rankingScore_hIndex
  • 277
is ?:relation_isRelatedTo_publication of
?:title
  • Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all